(NP (NP-COOD (NP (NN Surrogate) (NN thyroglobulin) (NNS receptors)) (CC and) (NP (NN T) (NN cell) (NN proliferation))) (PP (IN in) (NP (NP (NN Hashimoto) (POS 's)) (NN thyroiditis))) (. .))
(S (NP-SBJ (NP (NN Immunoglobulin) (NNS molecules)) (PP (IN on) (NP (NP (DT the) (NN surface)) (PP (IN of) (NP (DT a) (NN B) (NN lymphocyte)))))) (VP (VBP are) (NP-PRD (NP (DT the) (JJ endogenous) (`` ") (NNS receptors) ('' ")) (SBAR (WHPP-65 (TO to) (WHNP (WDT which))) (S (NP-SBJ (JJ specific) (NNS antigens)) (VP (VBP bind) (PP (-NONE- *T*-65))))))) (. .))
(S (NP-SBJ (NP (NNS Studies)) (PP (IN in) (NP (NNS mice)))) (VP (VBP have) (VP (VBN shown) (SBAR (IN that) (S (NP-SBJ-66 (NP (DT a) (JJ monoclonal) (NN antibody)) (, ,) (VP (VBN conjugated) (NP-68 (-NONE- *)) (PP (IN with) (NP (NN palmitate))) (S (NP-SBJ (-NONE- *-68)) (VP (TO to) (VP (VB provide) (NP (DT a) (NN lipid) (NN tail)))))) (, ,)) (VP (MD can) (VP (VB be) (VP (VBN inserted) (NP-67 (-NONE- *-66)) (PP (IN into) (NP (DT the) (NN cell) (NN membrane))) (S (NP-SBJ (-NONE- *-67)) (VP (TO to) (VP (VB provide) (NP (DT a) (`` ") (JJ surrogate) ('' ") (NN antigen) (NN receptor)))))))))))) (. .))
(S (NP-SBJ (PRP We)) (VP (VBP have) (VP (VBN investigated) (SBAR (IN whether) (S (NP-SBJ (NP (DT a) (JJ palmitate) (NN conjugate)) (PP (IN of) (NP (DT a) (JJ human) (JJ monoclonal) (NN antibody))) (ADJP (JJ specific) (PP (IN for) (NP (NP (NN thyroglobulin)) (PRN (-LRB- -LRB-) (NP (NN TG)) (-RRB- -RRB-)))))) (VP (MD could) (VP (VB function) (PP (IN as) (NP (DT a) (JJ surrogate) (NN TG) (NN receptor))) (PP (IN on) (NP (NP (NN blood) (JJ mononuclear) (NNS cells)) (VP (VBN separated) (NP (-NONE- *)) (PP (IN into) (NP (NP (NNS fractions)) (VP-COOD (VP (VBN enriched) (NP (-NONE- *)) (PP (IN for) (NP (NN T) (NNS cells)))) (CC or) (VP (VBN depleted) (NP (-NONE- *)) (PP (IN of) (NP (NP (NN T) (NNS cells)) (PRN (-LRB- -LRB-) (NP (JJ non-T) (NNS cells)) (-RRB- -RRB-))))))))))))))))) (. .))
(S (S-ADV (NP-SBJ (-NONE- *-69)) (VP (VBG Using) (NP (NN flow) (NN cytometry)))) (, ,) (NP-SBJ-69 (PRP we)) (VP (VBD detected) (NP (JJ surrogate) (NN TG) (NNS receptors)) (PP (PP-COOD (PP (IN on) (NP (JJ non-T) (NP (-NONE- *RNR*-70)))) (-LRB- -LRB-) (CC but) (PP (RB not) (IN on) (NP (NN T) (NP (-NONE- *RNR*-70)))) (-RRB- -RRB-)) (NP-70 (NP (NNS cells)) (PP (IN from) (NP (NP (NP (QP (CD 11) (IN of) (CD 11)) (NNS individuals)) (VP (VBN studied) (NP (-NONE- *)))) (PRN (-LRB- -LRB-) (NP-COOD (NP (CD 5) (NN Hashimoto) (NNS patients)) (CC and) (NP (CD 6) (NN control) (NNS donors))) (-RRB- -RRB-))))))) (. .))
(S (PP (IN In) (NP (NN contrast))) (, ,) (NP-SBJ-71 (JJ endogenous) (NN TG) (NNS receptors)) (VP (MD could) (ADVP (RB only)) (VP (VB be) (VP (VBN detected) (NP (-NONE- *-71)) (PP (IN on) (NP (NP (JJ non-T) (NNS cells)) (PP-COOD (PP (IN from) (NP (QP (CD 1) (IN of) (CD 3)) (NN Hashimoto) (NNS patients))) (CC and) (PP (IN from) (NP (QP (CD 0) (IN of) (CD 4)) (NN control) (NNS donors))))))))) (. .))
(S (PP (IN Because) (IN of) (NP (NP (DT the) (JJ efficient) (NN binding)) (PP (IN of) (NP (NN TG))) (PP (IN by) (NP (JJ surrogate) (NNS receptors))) (PP (IN on) (NP (JJ non-T) (NNS cells))))) (, ,) (NP-SBJ (PRP we)) (VP (VBD assessed) (NP (NP (NP (DT the) (NN ability) (S (-NONE- *ICH*-72))) (PP (IN of) (NP (JJ such) (NNS cells)))) (S-72 (NP-SBJ (-NONE- *)) (VP (TO to) (VP (VB present) (NP (NN TG)) (PP (TO to) (NP (NN T) (NNS cells)))))))) (. .))
(S (NP-SBJ-73 (NP (NN Proliferation)) (PP (IN in) (NN response) (TO to) (NP (NN TG)))) (VP (VBD was) (VP (VBN observed) (NP (-NONE- *-73)) (PP (IN in) (NP (NP (NN T) (NNS cells)) (PP (IN from) (NP (QP (RB only) (CD 1) (IN of) (CD 5)) (NN Hashimoto) (NNS patients))))))) (. .))
(S (NP-SBJ (NP (DT This) (JJ low) (NN frequency)) (PP (IN of) (NP (NN response)))) (VP (VBD was) (ADJP-PRD (RB no) (JJ different) (PP (IN from) (NP (NP (DT that)) (VP (ADVP (RB previously)) (VBN detected) (NP (-NONE- *)) (S (NP-SBJ (-NONE- *)) (VP (VBG using) (NP (NP (NNS cultures)) (PP (IN of) (NP-COOD (NP (NN T) (NNS cells)) (CC and) (NP (JJ autologous) (JJ dendritic) (NNS cells)))))))))))) (. .))
(S (ADVP (RB Therefore)) (, ,) (NP-SBJ-74 (NP (DT the) (JJ successful) (NN generation)) (PP (IN of) (NP (JJ surrogate) (NNS receptors))) (PP (IN on) (NP (JJ non-T) (NNS cells)))) (VP (VBZ is) (RB not) (VP (VBN associated) (NP (-NONE- *-74)) (PP (IN with) (NP (NP (ADJP (RBR more) (JJ efficient)) (NN TG) (NN presentation)) (PP (IN of) (NP (NN T) (NNS cells))))))) (. .))
(S (ADVP (RB Furthermore)) (, ,) (NP-SBJ (NP (DT the) (NN significance)) (PP (IN of) (NP (DT the) (JJ present) (NN study)))) (VP (VBZ is) (SBAR-PRD (IN that) (S (NP-SBJ-COOD-75 (NP (DT the) (NN T) (NNS cells)) (, ,) (RB not) (NP (DT the) (JJ antigen-presenting) (NNS cells)) (, ,)) (VP (VBP are) (ADJP-PRD (JJ likely) (S (NP-SBJ (-NONE- *-75)) (VP (TO to) (VP (VB be) (NP-PRD (NP (DT the) (VBG limiting) (NN element)) (PP (IN in) (NP (NP (DT the) (NN T) (NN cell) (JJ proliferative) (NN response)) (PP (TO to) (NP-COOD (NP (NN TG)) (CC and) (NP (JJ other) (NN thyroid) (NNS autoantigens))))))))))))))) (. .))
